← Back to Search

N/A

Optimizing Cognitive Remediation

N/A
Recruiting
Led By Yash B. Joshi, MD PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

Veterans with mental illness face challenges with community reintegration, including achieving vocational success, attaining their educational goals and going back to school, and maintaining a high quality of life. VA Mental Health Residential Rehabilitation Treatment Programs, Psychosocial Rehabilitation and Recovery Centers and other mental health treatment programs are designed to help Veterans overcome these barriers, but cognitive impairment often seen in Veterans with mental illness limits gains from these settings. Cognitive remediation interventions can be helpful, but they are either "one-size fits all," and thus may not be useful for all Veterans with mental illness, or are too narrow in scope, focusing on specific mental illnesses, limiting generalizability. This project will test whether an objective neurophysiological biomarker, mismatch negativity (MMN), can better match the "right" Veteran to the "right" cognitive remediation treatment regardless of their specific mental health diagnosis.

Eligible Conditions
  • Schizophrenia
  • Mood Disorder
  • Post-Traumatic Stress Disorder
  • Anxiety
  • Mood Disorders

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cognition
Cognitive training performance
Mismatch Negativity (electrophysiological biomarker)
+2 more
Other study objectives
Feasibility and acceptability of using biomarker-guided cognitive rehabilitation interventions in VA rehabilitation settings

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,668 Previous Clinical Trials
3,765,762 Total Patients Enrolled
45 Trials studying Schizophrenia
5,104 Patients Enrolled for Schizophrenia
Yash B. Joshi, MD PhDPrincipal InvestigatorVA San Diego Healthcare System, San Diego, CA
~20 spots leftby Jan 2026